Lentivirus-Induced Dendritic Cells for Immunization Against High-Risk WT1+ Acute Myeloid Leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lentivirus-Induced Dendritic Cells for Immunization Against High-Risk WT1+ Acute Myeloid Leukemia
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 24, Issue 2, Pages 220-237
Publisher
Mary Ann Liebert Inc
Online
2013-01-12
DOI
10.1089/hum.2012.128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identity, Potency, In Vivo Viability, and Scaling Up Production of Lentiviral Vector-Induced Dendritic Cells for Melanoma Immunotherapy
- (2012) Mudita Pincha et al. Human Gene Therapy Methods
- Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication
- (2011) Mareike Rickmann et al. ANNALS OF HEMATOLOGY
- Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination
- (2011) C. Pospori et al. BLOOD
- Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection
- (2011) A. Biffi et al. BLOOD
- Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells
- (2011) M Pincha et al. GENE THERAPY
- Wilms’ tumor protein and FLT3‐internal tandem duplication expression in patients withde novoacute myeloid leukemia
- (2011) B V Spassov et al. Hematology
- Preconditioning Therapy with Lentiviral Vector-Programmed Dendritic Cells Accelerates the Homeostatic Expansion of Antigen-Reactive Human T Cells in NOD.Rag1−/−.IL-2rγc−/− mice
- (2011) Gustavo Salguero et al. HUMAN GENE THERAPY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies
- (2011) D. L. Porter Hematology-American Society of Hematology Education Program
- Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
- (2010) P. G. Maslak et al. BLOOD
- T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy
- (2010) E. M. Sloand et al. BLOOD
- Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
- (2010) V. Gupta et al. BLOOD
- Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
- (2010) Jürgen Kuball et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lentiviral vectors for immunization: an inflammatory field
- (2010) Mudita Pincha et al. Expert Review of Vaccines
- Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies
- (2010) K. Rezvani et al. HAEMATOLOGICA
- Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
- (2010) Otto-Wilhelm Merten et al. HUMAN GENE THERAPY
- WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy
- (2010) H. Sugiyama JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
- (2010) V. F. Van Tendeloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
- (2009) U. Keilholz et al. BLOOD
- Interactive diagnostics in the indication to allogeneic SCT in AML
- (2009) U Bacher et al. BONE MARROW TRANSPLANTATION
- Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
- (2009) Daniela Cilloni et al. JOURNAL OF CLINICAL ONCOLOGY
- WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation
- (2009) G Weber et al. LEUKEMIA
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started